Michala Marcussen, global head of economics at Societe Generale says that 10-year Treasury yields could still hit 6 percent in 2017. » Read More
The managing director of Pimco had correctly predicted in September that the bond market was overestimating the possibility of tapering.
Alternative credit strategies are trending with mutual fund investors. But don’t be misled: cutting interest rate exposure means accepting new risks.
The cost of insuring one-year U.S. bonds against default rose above the rate of insuring five-year debt for the first time since July 2011.
There are still smart plays for bond investors regardless of when the Federal Reserve begins its slow down of bond buying, according to one analyst.
As fixed-income investors assume greater credit risk, financial advisors are concerned that bank loan funds could implode.
The panic in the bond market is actually a good thing, according to the chief macro strategist at one of the largest bond fund managers.
Government bonds are the priciest assets in the world, with Japanese debt topping the overpriced league, according to a report from Deutsche Bank.
Thought you had until 2015 before the bond squeeze? The last few months showed how costly that strategy could be, but there's still opportunity in bonds.
Investors are flocking to fixed income ETFs -- but they may be dangerous when rates rise.
The 10-year note auction was solid Tuesday and some strategists say investors will be "very worried about being short the market."
Investors looking to buy corporate bonds must temper their expectations for 2013.
CNBC's Rick Santelli weighs in on the impact of historically low interest rates.
Business icons and provocateurs share their innovative models. Learn how to upend old industries and start new ones that move markets.
A look at 50 private companies set to reshape the business landscape.
Take an in-depth look at the world of modern medicine - examining the treatments, companies and people making a difference in the way we treat illness and injuries today, and laying the foundation for the medical treatments of tomorrow.